Danielle M. Brander

67 posts

Danielle M. Brander

Danielle M. Brander

@dbranderMD

translational oncologist at Duke Cancer Institute / director CLL & Lymphoma research program / views and tweets are my own

Katılım Aralık 2019
262 Takip Edilen488 Takipçiler
Danielle M. Brander
Danielle M. Brander@dbranderMD·
@MrazLab Amazing - congratulations!! So honored to have known you these years and witness all you’ve accomplished.
English
0
0
1
121
Mraz Lab
Mraz Lab@MrazLab·
I am very honored to be named a Full Professor at Masaryk University. Big thanks to all the colleagues and collaborators that I was lucky to work with during the years, and my family for so much support.
Mraz Lab tweet media
English
19
2
126
8.8K
Danielle M. Brander retweetledi
Deborah Stephens
Deborah Stephens@DebbieMStephens·
Ask your doctor if you are considered high risk by the CLLIPI score. If so, you may qualify for this exciting study. #CLL @SWOG @BrianHill_MDPhD @mshadman @anthonymatomd @dbranderMD @DanilovLab
SWOG Cancer Research Network@SWOG

Venetoclax + obinutuzumab combo is approved as front-line tx for pts w #CLL. Can intervening early w this combo vs waiting for symptoms lengthen survival for pts w high-risk (CLL-IPI of 4+) CLL or small #lymphocytic #lymphoma? @SWOG S1925 trial. SWOG.org/clinical-trial… @NRGonc

English
0
3
13
0
Danielle M. Brander retweetledi
Toby Eyre
Toby Eyre@tobyeyre82·
Important MURANO tox ax @anthonymatomd @jeff_sharman et al 28% premature d/c VR<2y ⬇️ PFS in prem d/c ven for any reason (PD excluded;p<0.0001)+due to AE Interrupt for AE 69% / dose ⬇️ 23% both no impact on PFS/OS Tox mx+continued Rx important for VenR PFS outcome #CLL #lymsm
Toby Eyre tweet mediaToby Eyre tweet media
English
0
2
8
0
Danielle M. Brander
Danielle M. Brander@dbranderMD·
There may not have been an official ASH run this year, but anyone else still get in their #FauciFour ? If daily running is the secret to Dr Fauci leading the nation through this chaos, may I never stop. Also, the San Diego skyline has nothing on my view. #IRunForASH
Danielle M. Brander tweet media
English
1
0
24
0
Danielle M. Brander
Danielle M. Brander@dbranderMD·
Flashback Friday and my upcoming first Twitter-versary. This tweet from an amazing #cll leader, along with a little help from @chadinabhan and @anthonymatomd finally got me on board. Looking forward to #ash20 highlights and my first ash on Twitter.
English
2
2
11
0
Danielle M. Brander
Danielle M. Brander@dbranderMD·
@cmpabon Well said! Also sad that even when insurance “covers” - most patients are very much underinsured and co pays are limiting.
English
0
0
1
0
Cindy M. Pabon, MD
Cindy M. Pabon, MD@cmpabon·
Frontline therapy in #CLL has largely evolved with novel therapies in the last decade. Sad to hear that despite the data, sometimes we still choose chemoimmunotherapy if insurance doesn't cover targeted agents. Our healthcare system needs a makeover! #ASH2020 @ASH_hematology
Cindy M. Pabon, MD tweet media
English
1
0
6
0
Danielle M. Brander
Danielle M. Brander@dbranderMD·
To teach is to learn, twice And thankful for this opportunity from #ASH20, twice - to learn from so many others but also to work on this with an amazing fellow @DukeFellows, Dr Ashley Hanlon @amilliga, that has taught me so much and co authored this chapter #dukefamily
English
0
1
13
0
Danielle M. Brander
Danielle M. Brander@dbranderMD·
Intolerance is a failure of the medication for that given patient, patients don’t fail therapy. Grateful to be a part of this collaborative effort @DukeHMCT and for all trials aimed at the unmet need of intolerance. @anthonymatomd @AndreaSitlinger and many others
English
0
1
16
0